$ARMP
Armata Pharmaceuticals, Inc. Common Stock
XASE
$6.25
▲+16.26%+$0.875
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ARMP up today? It is at $6.25 (+16.26%), and our scanner flagged it 28 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARMP spikes, and full due diligence on ARMP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARMP 28 times in the last 30 days. Create a free account to track $ARMP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ARMP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on ARMP today, peaking at 5.9x its normal volume. Fresh from the SEC: Armata Pharmaceuticals Receives U.S. FDA Breakthrough. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystArmata Pharmaceuticals Receives U.S. FDA BreakthroughReported assessment, 28 days after completion of BAT, 100% of patients treated with AP-SA02 maintained clinical response without relapse, comparedReported with 75% of patients receiving placebo. Patients treated with AP-SA02 also demonstrated favorable trends across multiple measures of diseaseReported 3 clinical study, is partially supported by a $28.7 million Department of War (DoW) award, received through the Medical Technology, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Birx Deborah Officer | Sold (automatic/other) | -14K 0.04% of company | sold 6.6% | 198K | $60K at $4.26 | Jul 10, 26 |
Birx Deborah Officer | Sold (automatic/other) | -5K 0.01% of company | sold 2.3% | 212K | $52K at $10.54 | Mar 14, 26 |
Kyme Pierre Officer | Sold (automatic/other) | -1K | sold 9.8% | 9K | $11K at $10.54 | Mar 14, 26 |
Birx Deborah Officer | Sold (automatic/other) | -14K 0.04% of company | sold 5.9% | 217K | $31K at $2.27 | Jul 10, 25 |
Kyme Pierre Officer | Sold (automatic/other) | -1K | sold 8.9% | 10K | $2K at $1.95 | Mar 14, 25 |
Birx Deborah Officer | Sold (automatic/other) | -6K 0.02% of company | sold 2.6% | 231K | $12K at $1.95 | Mar 14, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
ARMP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on ARMP today, peaking at 5.9x its normal volume. Fresh from the SEC: Armata Pharmaceuticals Receives U.S. FDA Breakthrough. A material company disclosure like this is often the real catalyst behind a move of this size.
ARMP last traded at $6.25, up 16.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The ARMP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARMP 28 times in the last 30 days.
ARMP (Armata Pharmaceuticals, Inc. Common Stock) trades on XASE, with a market cap of about $200M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARMP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARMP discussion
Sign in to ask a question or join the discussion.